Guardant Health, Inc.
GH
$25.36
-$0.88-3.35%
| 03/31/2024 | 12/31/2023 | 09/30/2023 | 06/30/2023 | 03/31/2023 | |
|---|---|---|---|---|---|
| Revenue | 25.21% | 25.45% | 24.38% | 25.00% | 23.29% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 25.21% | 25.45% | 24.38% | 25.00% | 23.29% |
| Cost of Revenue | 34.87% | 45.24% | 48.40% | 46.33% | 40.64% |
| Gross Profit | 19.60% | 14.90% | 12.49% | 14.69% | 15.02% |
| SG&A Expenses | -5.24% | -3.08% | 3.14% | 12.19% | 19.29% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 1.07% | 5.40% | 13.62% | 22.08% | 27.42% |
| Operating Income | 19.87% | 11.26% | -4.22% | -19.48% | -31.23% |
| Income Before Tax | 30.66% | 26.73% | 26.59% | 4.74% | -65.68% |
| Income Tax Expenses | -39.42% | -39.86% | 233.58% | 174.67% | 745.18% |
| Earnings from Continuing Operations | 30.68% | 26.76% | 26.34% | 4.56% | -65.96% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 30.68% | 26.76% | 28.61% | 7.78% | -58.59% |
| EBIT | 19.87% | 11.26% | -4.22% | -19.48% | -31.23% |
| EBITDA | 22.17% | 13.43% | -2.28% | -17.62% | -29.48% |
| EPS Basic | 39.62% | 33.21% | 31.50% | 9.13% | -57.39% |
| Normalized Basic EPS | 51.91% | 41.57% | 30.27% | 16.84% | -42.52% |
| EPS Diluted | 39.62% | 33.21% | 31.50% | 9.13% | -57.39% |
| Normalized Diluted EPS | 51.91% | 41.57% | 30.27% | 16.84% | -42.52% |
| Average Basic Shares Outstanding | 13.98% | 9.54% | 5.84% | 2.27% | 0.83% |
| Average Diluted Shares Outstanding | 13.98% | 9.54% | 5.84% | 2.27% | 0.83% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |
